A Three-Part, Randomised Study to Investigate the Safety, Tolerability, Pharmacokinetics and Mode of Action of BC 007, Neutraliser of Pathogenic Autoantibodies Against G-Protein Coupled Receptors in Healthy, Young and Elderly Subjects
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
A Three-Part, Randomised Study to Investigate the Safety, Tolerability, Pharmacokinetics and Mode of Action of BC 007, Neutraliser of Pathogenic Autoantibodies Against G-Protein Coupled Receptors in Healthy, Young and Elderly Subjects
Authors
Keywords
-
Journal
CLINICAL DRUG INVESTIGATION
Volume 40, Issue 5, Pages 433-447
Publisher
Springer Science and Business Media LLC
Online
2020-03-28
DOI
10.1007/s40261-020-00903-9
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The aptamer BC 007 for treatment of dilated cardiomyopathy: evaluation in Doberman Pinschers of efficacy and outcomes
- (2020) Sabine Werner et al. ESC Heart Failure
- In-Vivo Degradation of DNA-Based Therapeutic BC 007 in Humans
- (2019) Hanna Davideit et al. EUROPEAN JOURNAL OF DRUG METABOLISM AND PHARMACOKINETICS
- Xenoreactive antibodies and latent fibrin formation in VAD and cardiac transplant recipients can confound the detection and measurement of anti-AT1R antibodies
- (2018) Martin Oaks et al. AMERICAN JOURNAL OF TRANSPLANTATION
- Antigen-free control wells in an ELISA set-up for the determination of autoantibodies against G protein-coupled receptors—a requisite for correct data evaluation
- (2018) Annekathrin Haberland et al. ANALYTICAL AND BIOANALYTICAL CHEMISTRY
- THE DNA-BASED THERAPEUTIC AGENT BC 007 COMPLETELY NEUTRALIZES AGONISTIC AUTOANTIBODIES DIRECTED AGAINST β1-ADRENOCEPTORS: RESULTS OF A PHASE 1 TRIAL
- (2018) Johannes Mueller et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Functional autoantibodies in patients with different forms of dementia
- (2018) Gerd Wallukat et al. PLoS One
- Aptamer BC007 for neutralization of pathogenic autoantibodies directed against G-protein coupled receptors: A vision of future treatment of patients with cardiomyopathies and positivity for those autoantibodies
- (2016) Gerd Wallukat et al. ATHEROSCLEROSIS
- Aptamer BC 007 – A broad spectrum neutralizer of pathogenic autoantibodies against G-protein-coupled receptors
- (2016) Annekathrin Haberland et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Pharmacokinetics and Safety of Single Intravenous Doses of JNJ-54452840, an Anti-β1-Adrenergic Receptor Antibody Cyclopeptide, in Healthy Male Japanese and Caucasian Participants
- (2015) Ivo P. Nnane et al. CLINICAL PHARMACOKINETICS
- Diagnostic and therapeutic aspects of β1-adrenergic receptor autoantibodies in human heart disease
- (2014) Beatrice Bornholz et al. AUTOIMMUNITY REVIEWS
- Agonistic autoantibodies directed against G-protein-coupled receptors and their relationship to cardiovascular diseases
- (2014) Gerd Wallukat et al. Seminars in Immunopathology
- Dilated cardiomyopathy: the complexity of a diverse genetic architecture
- (2013) Ray E. Hershberger et al. Nature Reviews Cardiology
- Long-term benefits of immunoadsorption in β1-adrenoceptor autoantibody-positive transplant candidates with dilated cardiomyopathy
- (2012) Michael Dandel et al. EUROPEAN JOURNAL OF HEART FAILURE
- Aliskiren, ALTITUDE, and the implications for ATMOSPHERE
- (2012) John J.V. McMurray et al. EUROPEAN JOURNAL OF HEART FAILURE
- 2009 Focused Update Incorporated Into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults
- (2009) Sharon Ann Hunt et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started